We also found that miR-125b-5p and downregulation of ATXN1 enhanced migration/invasion capability and stemness of HCC cells, and that overexpression of ATXN1 reverses EMT and sorafenib resistance. Here, ATXN1 is linked to hepatocellular carcinoma.